Evidence map›Paper›PMID 33029500›Full record

ArticleBioMed research international2020

Combined Pharmacotherapy with Alendronate and Desferoxamine Regulate the Bone Resorption and Bone Regeneration for Preventing Glucocorticoids-Induced Osteonecrosis of the Femoral Head.

Hongfeng Sheng, Yangjun Lao, Shuliang Zhang, Weiguo Ding, Di Lu, Bin Xu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hongfeng ShengDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.
Yangjun LaoDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.
Shuliang ZhangDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.
Weiguo DingDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.
Di LuDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.
Bin XuDepartment of Orthopaedics, Tongde Hospital of Zhejiang Province, 234# Gucui Road, Hangzhou 310012, China.ORCID https://orcid.org/0000-0003-0503-9986
Tongde Hospital of Zhejiang Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteonecrosis of the femoral head (ONFH) is a challenge for surgeons and is still without effective treatment method. This study is aimed at evaluating the combined pharmacotherapy with alendronate and desferoxamine for preventing glucocorticoid-induced osteonecrosis of the femoral head (GIOFH) and evaluating the efficacy of the combined medicine in regulating the bone resorption and bone regeneration. MATERIALS AND

methodsThirty-six rats were randomly assigned to three groups: group A received alendronate and desferoxamine (

resultsAccording to the results, alendronate administration improved the trabecular thickness and separation in micro-CT analysis but had no significant evidence in increasing the bone area and decreasing the ratio of osteocyte lacunae in histological analysis when compared with the control group. Meanwhile, the alendronate group had more OCs, but less OCN and VEGF levels along with decreased p-AKT, HIF-1

conclusionCombined pharmacotherapy with alendronate and desferoxamine provide significant effects in regulating the bone resorption and bone regeneration for preventing GIOFN.

Indexed as

Bone RegenerationAlendronateAnimalsbeta CateninBone ResorptionDeferoxamineDrug Therapy, CombinationFemur Head NecrosisGlucocorticoidsGlycogen Synthase Kinase 3 betaMaleNeovascularization, PhysiologicNFATC Transcription FactorsOsteogenesisRANK LigandRats, WistarAlendronatebeta CateninDeferoxamineGlucocorticoidsGlycogen Synthase Kinase 3 betaNFATC Transcription FactorsRANK LigandTartrate-Resistant Acid Phosphatase

Identifiers

PMID33029500
PMCPMC7532397
OpenAlexW3089259418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.